Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
Based on the success of tumor-infiltrating lymphocytes (TIL)-based therapies, personalized adoptive cell therapies (ACT) targeting neoantigens have the potential to become a disruptive technology and lead to highly effective treatments for cancer patients for whom no other options exist. ACT of TIL,...
Main Authors: | Florian Kast, Christian Klein, Pablo Umaña, Alena Gros, Stephan Gasser |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1869389 |
Similar Items
-
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01) -
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
by: Valentina Bianchi, et al.
Published: (2020-06-01) -
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
by: Else M. Inderberg, et al.
Published: (2017-04-01) -
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01) -
The Ways of Isolating Neoantigen-Specific T Cells
by: Qing Li, et al.
Published: (2020-08-01)